DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Univa Foods Limited — Board Meeting Intimation

NSE 4 hrs ago·6 Aug 2026, 1:14 pm

UNIVAFOODS NSE

Univa Foods Limited has announced that its board will meet on August 11, 2026, to review and approve its unaudited financial results for the quarter ending June 2026. This is a standard corporate procedure where the board reviews the company's performance before the results are officially disclosed to the public.

For investors, this meeting is a key event as it signals that the company is nearing the release of its latest financial data. The results will provide insights into the company's operational performance and financial health during the quarter, which is crucial for assessing its current trajectory.

Investors should watch for the specific release date of these results and the key metrics highlighted in the management commentary. Any significant deviations from market expectations could impact the stock's performance in the near term.